These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 3013763)
1. Polymorphisms within the HLA-DR3 haplotypes. I. HLA-DR polymorphisms detected at the protein and DNA levels are reflected by T-cell recognition. Bontrop R; Tilanus M; Mikulski M; van Eggermond M; Termijtelen A; Giphart M Immunogenetics; 1986; 23(6):401-5. PubMed ID: 3013763 [TBL] [Abstract][Full Text] [Related]
3. Functional and biochemical subtypes of the haplotype HLA-DR3 in patients with celiac disease or idiopathic membranous nephropathy. Sacks SH; Bushell A; Rust NA; Karagiannis JA; Jewell DP; Ledingham JG; Wood KJ; McMichael AJ Hum Immunol; 1987 Oct; 20(2):175-87. PubMed ID: 2960642 [TBL] [Abstract][Full Text] [Related]
4. Two variants of DRw52, DR3, and DQw2 specificities distinguish two different DR3-bearing extended haplotypes. Dasgupta JD; Relias V; Awdeh ZL; Alper CA; Yunis EJ Hum Immunol; 1988 Feb; 21(2):133-42. PubMed ID: 2835344 [TBL] [Abstract][Full Text] [Related]
5. Molecular localization of LB-Q1, a DRw52-like T-cell recognition epitope and identification at the genomic level of associated shared hybridizing fragments. Termijtelen A; Tilanus MG; Engelen I; Koning F; van Rood JJ Hum Immunol; 1987 Aug; 19(4):255-67. PubMed ID: 2445714 [TBL] [Abstract][Full Text] [Related]
6. Linkage of HLA-DR beta specific restriction fragment length polymorphisms with Graves' disease. Boehm BO; Schifferdecker E; Kuehnl P; Schöffling K Acta Endocrinol (Copenh); 1988 Oct; 119(2):251-6. PubMed ID: 2902722 [TBL] [Abstract][Full Text] [Related]
7. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity. Bontrop R; Ottenhoff T; Van Miltenburg R; Elferink D; De Vries R; Giphart M Eur J Immunol; 1986 Feb; 16(2):133-8. PubMed ID: 3485528 [TBL] [Abstract][Full Text] [Related]
8. Southern hybridization analysis of DNA polymorphism in the HLA-D region. Inoko H; Ando A; Ito M; Tsuji K Hum Immunol; 1986 Jul; 16(3):304-13. PubMed ID: 3013815 [TBL] [Abstract][Full Text] [Related]
9. Demonstration of two distinct light chains in HLA-DR-associated antigens by two-dimensional gel electrophoresis. de Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF Eur J Immunol; 1982 Mar; 12(3):214-21. PubMed ID: 6178597 [TBL] [Abstract][Full Text] [Related]
10. T cells specific for different antigens express different HLA-D region products. Schendel DJ; Johnson JP Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791 [TBL] [Abstract][Full Text] [Related]
11. HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants. Pious D; Dixon L; Levine F; Cotner T; Johnson R J Exp Med; 1985 Oct; 162(4):1193-207. PubMed ID: 2413154 [TBL] [Abstract][Full Text] [Related]
12. Serological biochemical and functional characterisation of three different HLA-DR monoclonal antibodies derived from C57BL6 mice. Sachs JA; Fernandez N; Kurpisz M; Okoye R; Ogilvie J; Awad J; Labeta M; Festenstein H Tissue Antigens; 1986 Oct; 28(4):199-207. PubMed ID: 2949394 [TBL] [Abstract][Full Text] [Related]
13. Polymorphism and complexity of HLA-DR: evidence for intra-HLA-DR region crossing-over events. Bontrop RE; Tilanus MG; Mikulski MM; Elferink DG; Termijtelen A; de Vries RR; van Rood JJ; Giphart MJ Immunogenetics; 1988; 27(1):40-5. PubMed ID: 3257099 [TBL] [Abstract][Full Text] [Related]
14. HLA-DR beta gene DNA polymorphisms revealed by Taq I correlate with HLA-DR specificities. Kohonen-Corish MR; Serjeantson SW Hum Immunol; 1986 Mar; 15(3):263-71. PubMed ID: 3007405 [TBL] [Abstract][Full Text] [Related]
15. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies. Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545 [TBL] [Abstract][Full Text] [Related]
16. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules. Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789 [TBL] [Abstract][Full Text] [Related]
18. Separation of four class II molecules from DR2 and DRw6 homozygous B lymphoid cell lines. Maeda H; Hirata R Immunogenetics; 1984; 20(6):639-47. PubMed ID: 6392082 [TBL] [Abstract][Full Text] [Related]
19. Linkage map of three HLA-DR beta-chain genes: evidence for a recent duplication event. Rollini P; Mach B; Gorski J Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7197-201. PubMed ID: 3933002 [TBL] [Abstract][Full Text] [Related]
20. A biochemical analysis of the secregation of HLA-DR heavy and light chains in a family studied by two-dimensional gel electrophoresis. Roux-Dosseto M; Rohner C; Birnbaum D; Bourgue F; Rebai N; Mawas C; Goridis C Ann Immunol (Paris); 1983; 134C(1):55-81. PubMed ID: 6407385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]